Proprietary AI analyst is now available
- Public Comps
- Global Health
Global Health Valuation Multiples
Discover revenue and EBITDA valuation multiples for Global Health and similar public comparables like Medicover, Kpj Healthcare, Mouwasat, Asker Healthcare Group and more.
Global Health Overview
About Global Health
Global Health Ltd operates as a private multi-specialty tertiary care provider operating in the North and East regions of India, with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology. Under the Medanta brand, it has a network of hospitals in operation (Gurugram, Indore, Ranchi, and Lucknow), a hospital that is under construction with an operational outpatient facility (Patna), and a hospital (Noida) planned for development. The Group operates Healthcare services as a single business segment in India, constituting a single geographical segment.
Founded
2004
HQ

Employees
9.7K
Website
Sectors
Financials (LTM)
EV
$3B
Valuation Multiples
Start free trialGlobal Health Financials
Global Health reported last 12-month revenue of $475M and EBITDA of $101M.
In the same LTM period, Global Health generated $369M in gross profit, $101M in EBITDA, and $61M in net income.
Revenue (LTM)
Global Health P&L
In the most recent fiscal year, Global Health reported revenue of $461M and EBITDA of $106M.
Global Health is profitable as of last fiscal year, with gross margin of 77%, EBITDA margin of 23%, and net margin of 13%.
Financial data powered by Morningstar, Inc.
Global Health Stock Performance
Global Health has current market cap of $3B, and enterprise value of $3B.
Market Cap Evolution
Global Health's stock price is $12.79.
Global Health share price increased by 2.7% in the last 30 days, and by 3.7% in the last year.
Global Health has an EPS (earnings per share) of $0.22.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3B | $3B | 1.6% | 2.7% | 24.2% | 3.7% | $0.22 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialGlobal Health Valuation Multiples
Global Health trades at 7.2x EV/Revenue multiple, and 34.1x EV/EBITDA.
EV / Revenue (LTM)
Global Health Financial Valuation Multiples
As of June 5, 2026, Global Health has market cap of $3B and EV of $3B.
Global Health has a P/E ratio of 56.6x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Global Health Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Global Health Margins & Growth Rates
Global Health grew revenue by 17% and EBITDA by 16% in the last fiscal year.
In the most recent fiscal year, Global Health reported gross margin of 77%, EBITDA margin of 23%, and net margin of 13%.
Global Health Margins
Global Health Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Global Health Operational KPIs
Global Health's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.0M for the same period.
Global Health's Rule of 40 is 41% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Global Health's Rule of X is 69% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Global Health Competitors
Global Health competitors include Medicover, Kpj Healthcare, Mouwasat, Asker Healthcare Group, Concentra Group, Krishna Institute, Meinian Onehealth, Option Care Health, IKS Health and LifeStance Health.
Most Global Health public comparables operate across Hospitals & Clinics.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.7x | 1.7x | 10.9x | 10.4x | |||
| 3.8x | 3.8x | 15.7x | 15.8x | |||
| 4.3x | 4.1x | 12.0x | 12.2x | |||
| 2.0x | 2.0x | 16.9x | 16.0x | |||
| 2.4x | 2.3x | 12.2x | 11.7x | |||
| 8.9x | 8.4x | 42.3x | 40.5x | |||
| 2.4x | 2.4x | 11.4x | 12.8x | |||
| 0.8x | 0.7x | 9.0x | 8.9x | |||
This data is available for Pro users. Sign up to see all Global Health competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Global Health
| When was Global Health founded? | Global Health was founded in 2004. |
| Where is Global Health headquartered? | Global Health is headquartered in India. |
| How many employees does Global Health have? | As of today, Global Health has over 9K employees. |
| Who is the CEO of Global Health? | Global Health's CEO is Pankaj Sahni. |
| Is Global Health publicly listed? | Yes, Global Health is a public company listed on National Stock Exchange of India. |
| What is the stock symbol of Global Health? | Global Health trades under MEDANTA ticker. |
| When did Global Health go public? | Global Health went public in 2022. |
| Who are competitors of Global Health? | Global Health main competitors include Medicover, Kpj Healthcare, Mouwasat, Asker Healthcare Group, Concentra Group, Krishna Institute, Meinian Onehealth, Option Care Health, IKS Health, LifeStance Health. |
| What is the current market cap of Global Health? | Global Health's current market cap is $3B. |
| What is the current revenue of Global Health? | Global Health's last 12 months revenue is $475M. |
| What is the current revenue growth of Global Health? | Global Health revenue growth (NTM/LTM) is 17%. |
| What is the current EV/Revenue multiple of Global Health? | Current revenue multiple of Global Health is 7.2x. |
| What is the current EBITDA of Global Health? | Global Health's last 12 months EBITDA is $101M. |
| What is Global Health's EBITDA margin? | Global Health's last 12 months EBITDA margin is 21%. |
| What is the current EV/EBITDA multiple of Global Health? | Current EBITDA multiple of Global Health is 34.1x. |
| What is the current FCF of Global Health? | Global Health's last 12 months FCF is ($11M). |
| What is Global Health's FCF margin? | Global Health's last 12 months FCF margin is (2%). |
| What is the current EV/FCF multiple of Global Health? | Current FCF multiple of Global Health is (309.8x). |
| How many companies Global Health has acquired to date? | Global Health hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Global Health has invested to date? | Global Health hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Global Health
Lists including Global Health
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.